Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? (Q36763610)

16 August 2017

1 reference

title

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF? (English)

1 reference

16 August 2017

1

Cashen AF

1 reference

16 August 2017

Lazarus HM

2

1 reference

16 August 2017

Devine SM

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

19 March 2007

1 reference

Bone Marrow Transplantation

16 August 2017

published in

1 reference

16 August 2017

volume

39

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

577-588

1 reference

Peripheral blood stem cell and bone marrow transplantation for solid tumors and lymphomas: hematologic recovery and costs. A randomized, controlled trial.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

The bicyclam AMD3100 story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Mobilization of hematopoietic primitive and committed progenitor cells into blood in mice by anti-vascular adhesion molecule-1 antibody alone or in combination with granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Peripheral blood stem cell mobilization. A role for CXC chemokines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

It's moving day: factors affecting peripheral blood stem cell mobilization and strategies for improvement [corrected].

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Novel transcription factors in human CD34 antigen-positive hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Modulation of hematopoietic stem cell homing and engraftment by CD26

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Characterization of hematopoietic progenitor mobilization in protease-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

HLA-identical stem cell transplantation: is there an optimal CD34 cell dose?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor for collection of peripheral blood progenitor cells from healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Not all healthy donors mobilize hematopoietic progenitor cells sufficiently after G-CSF administration to allow for subsequent CD34 purification of the leukapheresis product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Factors affecting PBSC mobilization and collection in healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Healthy sibling donor anxiety and pain during bone marrow or peripheral blood stem cell harvesting for allogeneic transplantation: results of a randomised study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G‐CSF‐induced spleen size changes in peripheral blood progenitor cell donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Transient spleen enlargement in peripheral blood progenitor cell donors given G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Splenic rupture in a parental donor undergoing peripheral blood progenitor cell mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Splenic rupture after granulocyte-colony-stimulating factor mobilization in a peripheral blood progenitor cell donor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Angina pectoris occurring during granulocyte colony-stimulating factor-combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G-CSF induces E-selectin ligand expression on human myeloid cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Evaluation of hematopoietic stem cell donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G-CSF and exacerbation of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Collection of hematopoietic stem cells from patients with autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The relative quiescence of hematopoietic stem cells in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Granulocyte colony-stimulating factor generates epigenetic and genetic alterations in lymphocytes of normal volunteer donors of stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The use of granulocyte colony-stimulating factor in volunteer blood and marrow registry donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Acute myelogenous leukemia in a donor after granulocyte colony-stimulating factor-primed peripheral blood stem cell harvest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Family history of cancer and incidence of acute leukemia in adults.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Familial aggregation of haematological neoplasms: a controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Weighing the risks of G-CSF administration, leukopheresis, and standard marrow harvest: ethical and safety considerations for normal pediatric hematopoietic cell donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Comparison between granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the mobilization of peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Randomized trial of filgrastim, sargramostim, or sequential sargramostim and filgrastim after myelosuppressive chemotherapy for the harvesting of peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with granulocyte-colony-stimulating factor by single-dose administration of AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

G-CSF-treated granulocytes inhibit acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Allogeneic Stem Cell Transplantation with Peripheral Blood Stem Cells Mobilized by Pegylated G-CSF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The stem-cell niche as an entity of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Osteoblastic cells regulate the haematopoietic stem cell niche

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Host origin of marrow stromal cells following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Stem Cell Mobilization Induced by Subcutaneous Granulocyte-Colony Stimulating Factor to Improve Cardiac Regeneration After Acute ST-Elevation Myocardial Infarction: Result of the Double-Blind, Randomized, Placebo-Controlled Stem Cells in Myocardial I

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705616

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705616

1 reference

Dimensions Publication ID

16 August 2017

1035969727

0 references

1 reference